Warhound Raises $200 Million for Dog Genetics

Warhound, a startup founded by Palmer Luckey, has raised $200 million to genetically enhance dogs for military service. The company plans to use gene editing to help canines detect explosives and protect troops. The funding was reported on October 23, 2026.

Sequoia is among the investors providing capital for the project. Colossal Biosciences is assisting with the cloning and gene-editing work. The animals will be modified to perform specific tasks in combat environments.

The startup aims to give military dogs biological advantages through genetic modification. The technology will allow the canines to identify threats more effectively. This approach combines biotechnology with traditional military canine training.

Investors are betting that genetic engineering can create specialized working dogs. The $200 million sum will fund the research and development phases. The partnership with Colossal Biosciences provides access to advanced genomic tools.

This development follows a trend of private companies entering the defense technology sector. The project represents a new application of gene editing in working animals. It also marks a major financial commitment to military biotech from a tech entrepreneur.

The company has not released detailed timelines for when the first gene-edited dogs will be deployed. The funding round includes both venture capital and strategic partners. The goal is to improve the efficiency of canine units in field operations.

The project positions Warhound as a leader in the emerging field of military genetics. The use of gene editing for this purpose is a departure from traditional breeding methods. Investors expect the technology to reduce the time needed to train specialized dogs.